Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine

Published:2021-03 Issue:3 Volume:9 Page:1121-1132.e7
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Pavord Ian D.,Menzies-Gow Andrew,Buhl Roland,Chanez Pascal,Dransfield Mark,Lugogo Njira,Keene Oliver N.,Bradford Eric S.,Yancey Steve W.

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference107 articles.

1. Global Strategy for Asthma Management and Prevention,2019

2. Omalizumab prescribing information,2019

3. A review of omalizumab for the management of severe asthma;Lin;Drug Des Devel Ther,2016

4. EU summary of product characteristics,2015

5. EU summary of product characteristics,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways;Immunological Reviews;2024-08-19

2. Single-cell proteomics and transcriptomics capture eosinophil development and identify the role of IL-5 in their lineage transit amplification;Immunity;2024-07

3. The Rebirth of Lebrikizumab for Airway Disease;The Journal of Allergy and Clinical Immunology: In Practice;2024-05

4. Real-World Effectiveness of Mepolizumab in Patients with Allergic and Non-Allergic Asthma;Journal of Asthma and Allergy;2024-03

5. Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis;The Journal of Allergy and Clinical Immunology: In Practice;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3